Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

Robert F. Kennedy Jr., if confirmed as HHS secretary, could help food-as-medicine startups expand with wider government health plan coverage.

According to Reuters, several major drugmakers, including Eli Lilly, are already planning to ask the Trump administration to pause the negotiations process. As a result, the Medicare negotiations’ ...